These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33011743)
1. Phage gene expression and host responses lead to infection-dependent costs of CRISPR immunity. Meaden S; Capria L; Alseth E; Gandon S; Biswas A; Lenzi L; van Houte S; Westra ER ISME J; 2021 Feb; 15(2):534-544. PubMed ID: 33011743 [TBL] [Abstract][Full Text] [Related]
2. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes. Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642 [TBL] [Abstract][Full Text] [Related]
3. Conditions for the spread of CRISPR-Cas immune systems into bacterial populations. Elliott JFK; McLeod DV; Taylor TB; Westra ER; Gandon S; Watson BNJ ISME J; 2024 Jan; 18(1):. PubMed ID: 38896653 [TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures. Watson BNJ; Capria L; Alseth EO; Pons BJ; Biswas A; Lenzi L; Buckling A; van Houte S; Westra ER; Meaden S ISME J; 2024 Jan; 18(1):. PubMed ID: 38366022 [TBL] [Abstract][Full Text] [Related]
5. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System. Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR mBio; 2021 Mar; 12(2):. PubMed ID: 33785624 [TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction. Watson BNJ; Staals RHJ; Fineran PC mBio; 2018 Feb; 9(1):. PubMed ID: 29440578 [TBL] [Abstract][Full Text] [Related]
7. The effect of Quorum sensing inhibitors on the evolution of CRISPR-based phage immunity in Pseudomonas aeruginosa. Broniewski JM; Chisnall MAW; Høyland-Kroghsbo NM; Buckling A; Westra ER ISME J; 2021 Aug; 15(8):2465-2473. PubMed ID: 33692485 [TBL] [Abstract][Full Text] [Related]
9. Phage-mediated resolution of genetic conflict alters the evolutionary trajectory of Suttenfield LC; Rapti Z; Chandrashekhar JH; Steinlein AC; Vera JC; Kim T; Whitaker RJ mSystems; 2024 Sep; 9(9):e0080124. PubMed ID: 39166874 [TBL] [Abstract][Full Text] [Related]
10. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci. Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355 [TBL] [Abstract][Full Text] [Related]
11. Variability in the durability of CRISPR-Cas immunity. Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283 [TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas systems restrict horizontal gene transfer in Pseudomonas aeruginosa. Wheatley RM; MacLean RC ISME J; 2021 May; 15(5):1420-1433. PubMed ID: 33349652 [TBL] [Abstract][Full Text] [Related]
13. Targeting of temperate phages drives loss of type I CRISPR-Cas systems. Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710 [TBL] [Abstract][Full Text] [Related]
14. Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses. Pons BJ; Dimitriu T; Westra ER; van Houte S Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216084120. PubMed ID: 36669116 [TBL] [Abstract][Full Text] [Related]
15. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity. Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217 [TBL] [Abstract][Full Text] [Related]